Cancer patients covered by Medi-Cal have lower survival rates; Pelosi and Reid work on Cadillac tax repeal;

News From Around the Web

> A new expensive cholesterol medicine may mean increased health insurance premiums for everyone, even those not taking the drug, contributor Ezekiel J. Emanuel writes in an opinion piece for the New York Times. Op-ed

> California cancer patients who are covered by Medi-Cal are less likely to receive recommended treatment and also have lower survival rates than patients who have other types of health coverage, according to a new study from the University of California-Davis Institute for Population Health Improvement. Study

> The top Democrats in the House and Senate--Nancy Pelosi and Harry Reid--are working together on an effort to repeal the Cadillac tax, The Hill reports. Article

 Health IT News

> A major database used to determine hospital reimbursement contains glaring flaws, according to research from the Johns Hopkins University School of Medicine. Article

AntiFraud News

> The shakeup continues for Philidor Rx Services LLC, which has dominated headlines over the last several weeks for its questionable relationship with pharmaceutical giant Valeant. Now, Reuters has reported that OptumRx, UnitedHealth's pharmacy benefit manager, sent cease-and-desist letters to Philidor last September, after discovering billing irregularities. Article

And finally… They missed the pasta and wine. Article

Suggested Articles

Regardless of who wins the elections in November, there are three issues that are going to dominate the healthcare discussion in Congress in 2021.

A new CMS report estimates that premiums for the second-cheapest silver tier plan will decline by 2% on HealthCare.gov next year.

Premiums on the ACA's exchanges for 2021 are expected to rise by about 1% as insurers struggle to figure out the impact of COVID-19, KFF report finds.